Dense metro markets with broad referral depth for studies that need urban reach.
Sponsor Network Review
Review ARI's western research footprint before you share a protocol.
ARI spans Los Angeles, San Francisco, and Las Vegas through one sponsor-facing relationship. Use this page to understand where each market fits, what each site can support, and how the network is managed.
Los Angeles · San Francisco · Las Vegas
350K+ patient access
One sponsor-facing team
Physician-led feasibility
Market atlas
Review all three markets in one view.
Start here if your team needs to understand where dense metro recruitment and senior-heavy prevalence fit inside the ARI network.
Senior-heavy communities and chronic disease prevalence that support age-related and longitudinal recruitment plans.
How sponsors use this page
Use the network page to understand footprint, market fit, and how ARI operates.
Sponsors use this page to qualify ARI's structure before moving to protocol-specific review.
Review the western footprint
Confirm whether Los Angeles, San Francisco, Las Vegas, or all three markets line up with your strategy.
Understand who the network can reach
Use the market mix to gauge urban density, referral patterns, and senior-population access relevant to your protocol.
Confirm one-team sponsor management
Centralized SOPs and sponsor communication reduce disconnected site-by-site conversations.
Ophthalmology
Retina
Glaucoma
Dry Eye
Thyroid Eye Disease
Rare Disease
Device
Phase I-IV
Advanced Imaging
Market comparison
Compare the network the way sponsor teams usually review it.
This board covers the basics for internal review: geography, patient access, protocol fit, and activation structure.
| Review lens | California markets | Las Vegas | Sponsor takeaway |
|---|---|---|---|
| Market logic | Dense metro markets in Los Angeles and San Francisco with broad referral reach and diverse patient populations. | Las Vegas concentrates senior-heavy communities and chronic disease prevalence in a fast-growing market. | Use California for broad urban reach, Las Vegas for age-related concentration, or both for mixed-market recruitment plans. |
| Best-fit programs | Strong fit for dense referral patterns, tertiary specialty access, and device or imaging-intensive workflows. | Strong fit for chronic disease, longitudinal follow-up, and protocols that benefit from retirement-age demographics. | ARI can recommend one market or a combined footprint based on study indication, visit cadence, and recruitment assumptions. |
| Patient-access angle | Metropolitan density supports varied referral sources and broad market coverage across California. | High-prevalence communities support efficient screening for age-related and chronic-condition cohorts. | The network gives sponsor teams one conversation for both volume-oriented and prevalence-oriented recruitment planning. |
| Activation model | Centralized SOPs, startup systems, and sponsor communication mirror the rest of the network. | Same operating model, quality systems, and sponsor contacts as the California sites. | Sponsors qualify one operating team across all markets instead of repeating review site by site. |
Research markets
Three research markets across the West.
Use these markets to decide where ARI best fits your protocol, recruitment assumptions, and startup needs.
California
Los Angeles & San Francisco
Major metropolitan research markets with diverse patient populations, strong referral networks, and established clinical research infrastructure.
Los Angeles
San Francisco
Nevada
Las Vegas
A large retirement-age population with high disease prevalence, especially useful for age-related conditions, chronic disease programs, and longitudinal treatment studies.
Las Vegas
One conversation, multi-site activation
One feasibility conversation covers every ARI site, with coordinated startup across all three markets.
Diverse patient populations
Urban coastal markets combined with high-prevalence retirement communities across the network.
Pair this page with the sponsor deck
Use the page for footprint review, then send the capabilities deck internally before moving to sponsor intake.
Study capabilities
Every site uses the same quality systems, compliance standards, and research processes.
Ophthalmology-rooted expertise
Board-certified ophthalmology investigators with fellowship training and 15+ industry-sponsored trials as principal investigators.
Advanced imaging infrastructure
Heidelberg Spectralis, OCT-A, FAF, visual field testing, and purpose-built clinical research facilities across the network.
Phase I–IV capability
Full-phase trial experience including complex interventional, rare disease, pediatric, and device protocols.
Hospital-adjacent context
Acute-care access and hospital governance experience for complex interventional and inpatient protocols.
